![](/img/cover-not-exists.png)
372PDFirst-in-human (FIH) study of TAS-120, a highly selective covalent oral fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced solid tumors
Kuboki, Y., Matsubara, N., Bando, H., Shitara, K., Yoh, K., Kojima, T., Ohno, I., Takahashi, H., Harano, K., Kondo, S., Hirai, H., Morizane, C., Doi, T.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx367.006
Date:
September, 2017
File:
PDF, 50 KB
english, 2017